Chopra, Rajiv
3 papers on CoChat
Most cited papers
- Verified
Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
LaRochelle, J. R., Fodor, M., Vemulapalli, V., Mohseni, M., Wang, P., Stams, T., LaMarche, M. J., Chopra, R., Acker, M. G., & Blacklow, S. C. (2018) · Nature Communications
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 167
- Verified
Abstract PR02: LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6– Reactivating Rb in cancer.
Kim, S., Loo, A., Chopra, R., Caponigro, G., Huang, A., Vora, S., Parasuraman, S., Howard, S., Keen, N., Sellers, W., et al. (2013) · Molecular Cancer Therapeutics
Advanced Breast Cancer TherapiesCancer-related Molecular Pathways
Cited by 106
- Verified
Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2
LaRochelle, J. R., Fodor, M., Xu, X., Durzynska, I., Fan, L., Stams, T., Chan, H. M., LaMarche, M. J., Chopra, R., Wang, P., et al. (2016) · Biochemistry
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 70
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free